| Title : High dose neostigmine treatment of malignant sinus tachycardia - Schultheis_1997_Pacing.Clin.Electrophysiol_20_1369 |
| Author(s) : Schultheis LW , Balser JR , Calkins H , Robertson S , Weiss JL , Sussman M , Stuart RS |
| Ref : Pacing Clin Electrophysiol , 20 :1369 , 1997 |
|
Abstract :
Sinus tachycardia caused by circulating catecholamines in the setting of congestive heart failure may impair systemic perfusion because of decreased diastolic filling time. We report the case of a patient with Wolff-Parkinson-White syndrome with angina and cardiogenic shock who improved dramatically following administration of neostigmine. Cardiac output, blood pressure, and stroke volume increased as heart rate was reduced. A previous attempt at heart rate control, in the same patient, using a low dose beta-antagonist, precipitated hemodynamic collapse. The remarkable recovery of our patient suggests that acetylcholinesterase inhibitors may warrant further investigation in patients with severe sinus tachycardia. |
| PubMedSearch : Schultheis_1997_Pacing.Clin.Electrophysiol_20_1369 |
| PubMedID: 9170142 |
| Inhibitor | Neostigmine~Prostigmine |
Schultheis LW, Balser JR, Calkins H, Robertson S, Weiss JL, Sussman M, Stuart RS (1997)
High dose neostigmine treatment of malignant sinus tachycardia
Pacing Clin Electrophysiol
20 :1369
Schultheis LW, Balser JR, Calkins H, Robertson S, Weiss JL, Sussman M, Stuart RS (1997)
Pacing Clin Electrophysiol
20 :1369